Cell Therapy Technologies Market by Product, Process, Cell type, Application, End user - Global Forecast to 2029

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
• 2.2 MARKET ESTIMATION METHODOLOGY
  • 2.2.1 MARKET ESTIMATION
  • 2.2.2 INSIGHTS FROM PRIMARY EXPERTS
  • 2.2.3 SEGMENTAL MARKET ESTIMATION (TOP-DOWN APPROACH)
• 2.3 MARKET GROWTH RATE PROJECTIONS
• 2.4 DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 CELL THERAPY TECHNOLOGIES MARKET OVERVIEW
• 4.2 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT AND COUNTRY (2023)
• 4.3 CELL THERAPY TECHNOLOGIES MARKET SHARE, BY PRODUCT, 2024 VS. 2029
• 4.4 CELL THERAPY TECHNOLOGIES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increased funding and investment in cell therapy
    • 5.2.1.2 Advancements in gene editing technologies
    • 5.2.1.3 Development of automated cell processing systems
    • 5.2.1.4 Regulatory support for fast-tracking therapies
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Manufacturing and logistical complexity
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Personalized and off-the-shelf cell therapies
    • 5.2.3.2 Integration with digital technologies such as AI & ML
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Supply chain & cold chain management and manufacturing scalability & quality control
• 5.3 ECOSYSTEM ANALYSIS
  • 5.3.1 PRODUCT PROVIDERS
  • 5.3.2 END USERS
  • 5.3.3 REGULATORY BODIES
• 5.4 TECHNOLOGY ANALYSIS
  • 5.4.1 KEY TECHNOLOGIES
    • 5.4.1.1 Magnetic-activated cell sorting
    • 5.4.1.2 Cryopreservation
    • 5.4.1.3 Gene editing technologies
    • 5.4.1.4 Bioprocessing technologies
  • 5.4.2 COMPLEMENTARY TECHNOLOGIES
    • 5.4.2.1 Artificial intelligence and machine learning
    • 5.4.2.2 Biomaterials and scaffolding
    • 5.4.2.3 Automation and scalability
  • 5.4.3 ADJACENT TECHNOLOGIES
    • 5.4.3.1 Nanotechnology
    • 5.4.3.2 Immunotherapy platforms
• 5.5 PRICING ANALYSIS
  • 5.5.1 AVERAGE SELLING PRICE TREND OF CELL THERAPY PRODUCTS, BY KEY PLAYER, 2022-2024
  • 5.5.2 AVERAGE SELLING PRICE TREND OF CELL THERAPY EQUIPMENT, BY REGION, 2022-2024
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 PATENT ANALYSIS
• 5.8 TRADE ANALYSIS
  • 5.8.1 IMPORT DATA FOR MACHINES AND APPARATUS FOR ELECTROPLATING, ELECTROLYSIS, OR ELECTROPHORESIS (HS CODE: 854330)
  • 5.8.2 EXPORT DATA FOR MACHINES AND APPARATUS FOR ELECTROPLATING, ELECTROLYSIS, OR ELECTROPHORESIS (HS CODE: 854330)
• 5.9 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.10 REGULATORY LANDSCAPE
  • 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10.2 REGULATORY FRAMEWORK
    • 5.10.2.1 North America
    • 5.10.2.2 Europe
    • 5.10.2.3 Asia Pacific
    • 5.10.2.4 Rest of the World
• 5.11 PORTER'S FIVE FORCES ANALYSIS
  • 5.11.1 THREAT OF NEW ENTRANTS
  • 5.11.2 THREAT OF SUBSTITUTES
  • 5.11.3 BARGAINING POWER OF BUYERS
  • 5.11.4 BARGAINING POWER OF SUPPLIERS
  • 5.11.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.12.1 KEY STAKEHOLDERS
  • 5.12.2 BUYING CRITERIA
• 5.13 INVESTMENT & FUNDING SCENARIO
• 5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES
• 5.15 IMPACT OF AI/GEN AI ON CELL THERAPY TECHNOLOGIES MARKET

6 CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT

• 6.1 INTRODUCTION
• 6.2 MEDIA, SERA, AND REAGENTS
  • 6.2.1 IMPORTANCE OF MEDIA, SERA, AND REAGENTS IN CELL PROCESSING TO DRIVE MARKET
• 6.3 CELL THERAPY EQUIPMENT
  • 6.3.1 CELL PROCESSING EQUIPMENT
    • 6.3.1.1 Development of automated and closed-system cell processing equipment to accelerate segment growth
  • 6.3.2 SINGLE-USE EQUIPMENT
    • 6.3.2.1 Increasing funding for stem cell therapy to drive market
  • 6.3.3 OTHER CELL THERAPY EQUIPMENT
• 6.4 SYSTEMS & SOFTWARE
  • 6.4.1 RISING DEMAND FOR CELL THERAPIES TO SUPPORT MARKET GROWTH
• 6.5 CELL CULTURE VESSELS
  • 6.5.1 RISING R&D AND INVESTMENTS IN CELL-BASED THERAPIES TO DRIVE DEMAND
• 6.6 CELL ENGINEERING PRODUCTS
  • 6.6.1 AVAILABILITY OF WIDE RANGE OF CELL ENGINEERING PRODUCTS TO SUPPORT MARKET
• 6.7 OTHER PRODUCTS

7 CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS

• 7.1 INTRODUCTION
• 7.2 CELL PROCESSING
  • 7.2.1 CELL EXPANSION
    • 7.2.1.1 Rising demand for personalized and regenerative therapies to drive market growth
  • 7.2.2 CELL ISOLATION
    • 7.2.2.1 Rising need for scalable, efficient isolation technologies to drive market
  • 7.2.3 CELL CHARACTERIZATION
    • 7.2.3.1 Increasing demand for high-quality, safe, and effective cell-based therapies to propel growth
  • 7.2.4 CELL COLLECTION
    • 7.2.4.1 Advancements in cell collection technologies to drive market
• 7.3 CELL PRESERVATION
  • 7.3.1 ADVANCEMENT IN CRYOPRESERVATION TECHNOLOGIES TO DRIVE GROWTH
• 7.4 PROCESS MONITORING & QUALITY CONTROL
  • 7.4.1 INCREASING DEMAND FOR AUTOMATED QUALITY CONTROL IN CELL THERAPY PRODUCTION TO DRIVE MARKET
• 7.5 CELL HANDLING
  • 7.5.1 INCREASING DEMAND FOR AUTOMATED, EFFICIENT, AND SCALABLE SOLUTIONS TO DRIVE MARKET GROWTH
• 7.6 CELL DISTRIBUTION
  • 7.6.1 INCREASED FOCUS ON TRANSPORTATION AND STORAGE TO DRIVE MARKET GROWTH

8 CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE

• 8.1 INTRODUCTION
• 8.2 T CELLS
  • 8.2.1 RISING RESEARCH ON CAR T-CELL THERAPY TO ACCELERATE GROWTH
• 8.3 STEM CELLS
  • 8.3.1 INCREASING FUNDING FOR STEM CELL RESEARCH TO PROPEL MARKET
• 8.4 OTHER CELLS

9 CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION

• 9.1 INTRODUCTION
• 9.2 CANCER
  • 9.2.1 RISING RESEARCH ON CAR T-CELL THERAPY TO ACCELERATE SEGMENT GROWTH
• 9.3 CARDIOVASCULAR DISEASE
  • 9.3.1 INCREASING FOCUS ON INNOVATIVE CELL THERAPY APPROACHES TO DRIVE MARKET
• 9.4 ORTHOPEDIC DISORDERS
  • 9.4.1 INCREASING FOCUS ON STEM CELL THERAPY FOR TISSUE REGENERATION TO DRIVE MARKET
• 9.5 AUTOIMMUNE DISEASES
  • 9.5.1 INCREASING FUNDING FOR STEM CELL RESEARCH TO SUPPORT MARKET GROWTH
• 9.6 OTHER APPLICATIONS

10 CELL THERAPY TECHNOLOGIES MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.2.1 INCREASING ADOPTION OF INORGANIC GROWTH STRATEGIES BY BIOPHARMACEUTICAL COMPANIES TO DRIVE MARKET
• 10.3 CROS & CMOS
  • 10.3.1 FOCUS ON OUTSOURCING TO DRIVE SEGMENT GROWTH
• 10.4 RESEARCH INSTITUTES
  • 10.4.1 RISING RESEARCH ACTIVITY TO SUPPORT MARKET GROWTH
• 10.5 CELL BANKS
  • 10.5.1 INCREASING DEMAND FOR STANDARDIZED CELL LINES TO SUPPORT MARKET GROWTH

11 CELL THERAPY TECHNOLOGIES MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 11.2.2 US
    • 11.2.2.1 US dominates North American cell therapy technologies market
  • 11.2.3 CANADA
    • 11.2.3.1 Increasing government funding to drive adoption of cell therapy instruments
• 11.3 EUROPE
  • 11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 11.3.2 GERMANY
    • 11.3.2.1 Germany to hold largest market share
  • 11.3.3 UK
    • 11.3.3.1 Favorable funding & investment scenario to drive market growth
  • 11.3.4 FRANCE
    • 11.3.4.1 Availability of government & private funding to support market growth
  • 11.3.5 ITALY
    • 11.3.5.1 Increasing R&D, public & private investment, and support to offer growth opportunities
  • 11.3.6 SPAIN
    • 11.3.6.1 Advancement in personalized medicine to stimulate market
  • 11.3.7 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 11.4.2 CHINA
    • 11.4.2.1 Increasing R&D expenditure to drive market growth
  • 11.4.3 JAPAN
    • 11.4.3.1 Strong availability of funding to support market growth
  • 11.4.4 INDIA
    • 11.4.4.1 Rising funding programs to drive market
  • 11.4.5 AUSTRALIA
    • 11.4.5.1 Increasing government funding & initiatives to drive market growth
  • 11.4.6 SOUTH KOREA
    • 11.4.6.1 Alliances & investments in research to drive market
  • 11.4.7 REST OF ASIA PACIFIC
• 11.5 LATIN AMERICA
  • 11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 11.5.2 BRAZIL
    • 11.5.2.1 Brazil to dominate Latin American market till 2029
  • 11.5.3 MEXICO
    • 11.5.3.1 Strong pharmaceutical industry and increased government support to augment market
  • 11.5.4 REST OF LATIN AMERICA
• 11.6 MIDDLE EAST
  • 11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST
  • 11.6.2 GCC COUNTRIES
    • 11.6.2.1 Saudi Arabia
      • 11.6.2.1.1 Increasing government investments in healthcare and growing pharmaceuticals industry to support market
    • 11.6.2.2 UAE
      • 11.6.2.2.1 Growing R&D expenditure & well-established class infrastructure to drive market
    • 11.6.2.3 Rest of GCC Countries
  • 11.6.3 REST OF MIDDLE EAST
• 11.7 AFRICA
  • 11.7.1 MACROECONOMIC OUTLOOK FOR AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CELL THERAPY TECHNOLOGIES MARKET
• 12.3 REVENUE ANALYSIS
• 12.4 MARKET SHARE ANALYSIS
• 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
    • 12.5.5.1 Company footprint
    • 12.5.5.2 Region footprint
    • 12.5.5.3 Product footprint
    • 12.5.5.4 Process footprint
    • 12.5.5.5 Cell type footprint
    • 12.5.5.6 Application footprint
• 12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • 12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
• 12.7 COMPANY VALUATION & FINANCIAL METRICS
  • 12.7.1 FINANCIAL METRICS
  • 12.7.2 COMPANY VALUATION
• 12.8 BRAND/PRODUCT COMPARISON
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES
  • 12.9.2 DEALS
  • 12.9.3 EXPANSIONS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 DANAHER CORPORATION
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Product launches
      • 13.1.1.3.2 Deals
      • 13.1.1.3.3 Expansions
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses and competitive threats
  • 13.1.2 MERCK KGAA
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Deals
      • 13.1.2.3.2 Expansions
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses and competitive threats
  • 13.1.3 THERMO FISHER SCIENTIFIC INC.
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Product launches
      • 13.1.3.3.2 Deals
      • 13.1.3.3.3 Expansions
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses and competitive threats
  • 13.1.4 LONZA
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Product launches
      • 13.1.4.3.2 Deals
  • 13.1.5 SARTORIUS AG
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Product launches
      • 13.1.5.3.2 Deals
      • 13.1.5.3.3 Expansions
  • 13.1.6 AGILENT TECHNOLOGIES, INC.
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches
      • 13.1.6.3.2 Deals
  • 13.1.7 AVANTOR, INC.
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products offered
    • 13.1.7.3 Recent developments
      • 13.1.7.3.1 Deals
  • 13.1.8 FRESENIUS SE & CO. KGAA
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products offered
    • 13.1.8.3 Recent developments
      • 13.1.8.3.1 Deals
  • 13.1.9 BECTON, DICKINSON AND COMPANY
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products offered
    • 13.1.9.3 Recent developments
      • 13.1.9.3.1 Product launches
  • 13.1.10 CORNING INCORPORATED
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products offered
  • 13.1.11 TERUMO CORPORATION
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products offered
    • 13.1.11.3 Recent developments
      • 13.1.11.3.1 Product launches
      • 13.1.11.3.2 Deals
      • 13.1.11.3.3 Expansions
  • 13.1.12 BIO-TECHNE
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products offered
    • 13.1.12.3 Recent developments
      • 13.1.12.3.1 Product launches
      • 13.1.12.3.2 Deals
      • 13.1.12.3.3 Other developments
  • 13.1.13 GENSCRIPT
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products offered
    • 13.1.13.3 Recent developments
      • 13.1.13.3.1 Deals
  • 13.1.14 MAXCYTE
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products offered
    • 13.1.14.3 Recent developments
      • 13.1.14.3.1 Deals
  • 13.1.15 STEMCELL TECHNOLOGIES
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products offered
    • 13.1.15.3 Recent developments
      • 13.1.15.3.1 Product launches
      • 13.1.15.3.2 Deals
• 13.2 OTHER PLAYERS
  • 13.2.1 OXFORD BIOMEDICA PLC
  • 13.2.2 ROOSTERBIO, INC.
  • 13.2.3 TRAKCEL
  • 13.2.4 L7 INFORMATICS, INC.
  • 13.2.5 MILTENYI BIOTEC
  • 13.2.6 REPLIGEN CORPORATION
  • 13.2.7 MAK SYSTEM
  • 13.2.8 ORIGEN BIOMEDICAL, INC.
  • 13.2.9 IXCELLS BIOTECHNOLOGIES
  • 13.2.10 KORBER AG

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS

List of Tables

• TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
• TABLE 2 CELL THERAPY TECHNOLOGIES MARKET: RISK ANALYSIS
• TABLE 3 CELL THERAPY TECHNOLOGIES MARKET: KEY PRODUCT PROVIDERS
• TABLE 4 CELL THERAPY TECHNOLOGIES MARKET: KEY END USERS
• TABLE 5 CELL THERAPY TECHNOLOGIES MARKET: REGULATORY BODIES
• TABLE 6 AVERAGE SELLING PRICE TREND OF CELL THERAPY PRODUCTS, BY KEY PLAYER, 2022-2024
• TABLE 7 AVERAGE SELLING PRICE TREND OF CELL THERAPY EQUIPMENT, BY REGION, 2022-2024
• TABLE 8 KEY PATENTS IN CELL THERAPY TECHNOLOGIES MARKET, 2021-2024
• TABLE 9 IMPORT VOLUME FOR HS CODE 854330, 2019-2023 (UNITS)
• TABLE 10 EXPORT VOLUME FOR HS CODE 854330, 2019-2023 (UNITS)
• TABLE 11 CELL THERAPY TECHNOLOGIES MARKET: DETAILED LIST OF CONFERENCES & EVENTS
• TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 15 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• TABLE 16 CELL THERAPY TECHNOLOGIES MARKET: PORTER'S FIVE FORCES ANALYSIS
• TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS
• TABLE 18 KEY BUYING CRITERIA FOR CELL THERAPY TECHNOLOGIES PRODUCTS, BY END USER
• TABLE 19 CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 20 CELL THERAPY MEDIA, SERA, AND REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 21 NORTH AMERICA: CELL THERAPY MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 22 EUROPE: CELL THERAPY MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 23 ASIA PACIFIC: CELL THERAPY MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 24 LATIN AMERICA: CELL THERAPY MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 25 MIDDLE EAST: CELL THERAPY MEDIA, SERA, AND REAGENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 26 GCC COUNTRIES: CELL THERAPY MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 27 CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 28 CELL THERAPY EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 29 NORTH AMERICA: CELL THERAPY EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 30 EUROPE: CELL THERAPY EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 31 ASIA PACIFIC: CELL THERAPY EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 32 LATIN AMERICA: CELL THERAPY EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 33 MIDDLE EAST: CELL THERAPY EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 34 GCC COUNTRIES: CELL THERAPY EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 35 CELL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 36 NORTH AMERICA: CELL PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 37 EUROPE: CELL PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 38 ASIA PACIFIC: CELL PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 39 LATIN AMERICA: CELL PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 40 MIDDLE EAST: CELL PROCESSING EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 41 GCC COUNTRIES: CELL PROCESSING EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 42 SINGLE-USE EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 43 NORTH AMERICA: SINGLE-USE EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 44 EUROPE: SINGLE-USE EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 45 ASIA PACIFIC: SINGLE-USE EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 46 LATIN AMERICA: SINGLE-USE EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 47 MIDDLE EAST: SINGLE-USE EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 48 GCC COUNTRIES: SINGLE-USE EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 49 OTHER CELL THERAPY EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 50 NORTH AMERICA: OTHER CELL THERAPY EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 51 EUROPE: OTHER CELL THERAPY EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 52 ASIA PACIFIC: OTHER CELL THERAPY EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 53 LATIN AMERICA: OTHER CELL THERAPY EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 54 MIDDLE EAST: OTHER CELL THERAPY EQUIPMENT MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 55 GCC COUNTRIES: OTHER CELL THERAPY EQUIPMENT MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 56 CELL THERAPY SYSTEMS & SOFTWARE, BY COMPANY
• TABLE 57 CELL THERAPY SYSTEMS & SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 58 NORTH AMERICA: CELL THERAPY SYSTEMS & SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 59 EUROPE: CELL THERAPY SYSTEMS & SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 60 ASIA PACIFIC: CELL THERAPY SYSTEMS & SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 61 LATIN AMERICA: CELL THERAPY SYSTEMS & SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 62 MIDDLE EAST: CELL THERAPY SYSTEMS & SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 63 GCC COUNTRIES: CELL THERAPY SYSTEMS & SOFTWARE MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 64 CELL CULTURE VESSELS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 65 NORTH AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 66 EUROPE: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 67 ASIA PACIFIC: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 68 LATIN AMERICA: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 69 MIDDLE EAST: CELL CULTURE VESSELS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 70 GCC COUNTRIES: CELL CULTURE VESSELS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 71 CELL ENGINEERING PRODUCTS OFFERED, BY COMPANY
• TABLE 72 CELL ENGINEERING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 73 NORTH AMERICA: CELL ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 74 EUROPE: CELL ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 75 ASIA PACIFIC: CELL ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 76 LATIN AMERICA: CELL ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 77 MIDDLE EAST: CELL ENGINEERING PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 78 GCC COUNTRIES: CELL ENGINEERING PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 79 OTHER CELL THERAPY PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 80 NORTH AMERICA: OTHER CELL THERAPY PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 81 EUROPE: OTHER CELL THERAPY PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 82 ASIA PACIFIC: OTHER CELL THERAPY PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 83 LATIN AMERICA: OTHER CELL THERAPY PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 84 MIDDLE EAST: OTHER CELL THERAPY PRODUCTS MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 85 GCC COUNTRIES: OTHER CELL THERAPY PRODUCTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 86 CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 87 CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 88 CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY REGION, 2022-2029 (USD MILLION)
• TABLE 89 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 90 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 91 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 92 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 93 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY REGION, 2022-2029 (USD MILLION)
• TABLE 94 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 95 CELL THERAPY TECHNOLOGIES MARKET FOR CELL EXPANSION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 96 CELL THERAPY TECHNOLOGIES MARKET FOR CELL EXPANSION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 97 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL EXPANSION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 98 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CELL EXPANSION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 99 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL EXPANSION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 100 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CELL EXPANSION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 101 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CELL EXPANSION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 102 CELL THERAPY TECHNOLOGIES MARKET FOR CELL ISOLATION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 103 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 104 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 105 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 106 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 107 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CELL ISOLATION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 108 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CELL ISOLATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 109 CELL THERAPY TECHNOLOGIES MARKET FOR CELL CHARACTERIZATION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 110 CELL THERAPY TECHNOLOGIES MARKET FOR CELL CHARACTERIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 111 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL CHARACTERIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 112 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CELL CHARACTERIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 113 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL CHARACTERIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 114 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CELL CHARACTERIZATION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 115 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CELL CHARACTERIZATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 116 CELL THERAPY TECHNOLOGIES MARKET FOR CELL COLLECTION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 117 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL COLLECTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 118 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL COLLECTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 119 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CELL COLLECTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 120 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL COLLECTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 121 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CELL COLLECTION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 122 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CELL COLLECTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 123 CELL THERAPY TECHNOLOGIES MARKET FOR CELL PRESERVATION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 124 CELL THERAPY TECHNOLOGIES MARKET FOR CELL PRESERVATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 125 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PRESERVATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 126 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PRESERVATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 127 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PRESERVATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 128 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PRESERVATION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 129 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PRESERVATION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 130 CELL THERAPY TECHNOLOGIES MARKET FOR PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2022-2029 (USD MILLION)
• TABLE 131 CELL THERAPY TECHNOLOGIES MARKET FOR PROCESS MONITORING & QUALITY CONTROL, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 132 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR PROCESS MONITORING & QUALITY CONTROL, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 133 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR PROCESS MONITORING & QUALITY CONTROL, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 134 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR PROCESS MONITORING & QUALITY CONTROL, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 135 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR PROCESS MONITORING & QUALITY CONTROL, BY REGION, 2022-2029 (USD MILLION)
• TABLE 136 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR PROCESS MONITORING & QUALITY CONTROL, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 137 CELL THERAPY TECHNOLOGIES MARKET FOR CELL HANDLING, BY REGION, 2022-2029 (USD MILLION)
• TABLE 138 CELL THERAPY TECHNOLOGIES MARKET FOR CELL HANDLING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 139 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL HANDLING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 140 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CELL HANDLING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 141 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL HANDLING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 142 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CELL HANDLING, BY REGION, 2022-2029 (USD MILLION)
• TABLE 143 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CELL HANDLING, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 144 CELL THERAPY TECHNOLOGIES MARKET FOR CELL DISTRIBUTION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 145 CELL THERAPY TECHNOLOGIES MARKET FOR CELL DISTRIBUTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 146 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL DISTRIBUTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 147 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CELL DISTRIBUTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 148 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL DISTRIBUTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 149 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CELL DISTRIBUTION, BY REGION, 2022-2029 (USD MILLION)
• TABLE 150 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CELL DISTRIBUTION, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 151 CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 152 T-CELL THERAPY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 153 NORTH AMERICA: T-CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 154 EUROPE: T-CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 155 ASIA PACIFIC: T-CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 156 LATIN AMERICA: T-CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 157 MIDDLE EAST: T-CELL THERAPY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 158 GCC COUNTRIES: T-CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 159 STEM CELL THERAPY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 160 NORTH AMERICA: STEM CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 161 EUROPE: STEM CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 162 ASIA PACIFIC: STEM CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 163 LATIN AMERICA: STEM CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 164 MIDDLE EAST: STEM CELL THERAPY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 165 GCC COUNTRIES: STEM CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 166 OTHER CELL THERAPY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 167 NORTH AMERICA: OTHER CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 168 EUROPE: OTHER CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 169 ASIA PACIFIC: OTHER CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 170 LATIN AMERICA: OTHER CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 171 MIDDLE EAST: OTHER CELL THERAPY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 172 GCC COUNTRIES: OTHER CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 173 CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 174 CELL THERAPY TECHNOLOGIES MARKET FOR CANCER, BY REGION, 2022-2029 (USD MILLION)
• TABLE 175 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 176 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 177 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 178 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 179 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CANCER, BY REGION, 2022-2029 (USD MILLION)
• TABLE 180 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CANCER, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 181 CELL THERAPY TECHNOLOGIES MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2022-2029 (USD MILLION)
• TABLE 182 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 183 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 184 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 185 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 186 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CARDIOVASCULAR DISEASE, BY REGION, 2022-2029 (USD MILLION)
• TABLE 187 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CARDIOVASCULAR DISEASE, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 188 CELL THERAPY TECHNOLOGIES MARKET FOR ORTHOPEDIC DISORDERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 189 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR ORTHOPEDIC DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 190 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR ORTHOPEDIC DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 191 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR ORTHOPEDIC DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 192 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR ORTHOPEDIC DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 193 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR ORTHOPEDIC DISORDERS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 194 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR ORTHOPEDIC DISORDERS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 195 CELL THERAPY TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 196 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 197 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 198 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 199 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 200 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 201 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 202 CELL THERAPY TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 203 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 204 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 205 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 206 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 207 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 208 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 209 CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 210 CELL THERAPY TECHNOLOGIES MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 211 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 212 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 213 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 214 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 215 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 216 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR BIOPHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 217 CELL THERAPY TECHNOLOGIES MARKET FOR CROS & CMOS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 218 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 219 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 220 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 221 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 222 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CROS & CMOS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 223 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CROS & CMOS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 224 CELL THERAPY TECHNOLOGIES MARKET FOR RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 225 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 226 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 227 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 228 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 229 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
• TABLE 230 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 231 CELL THERAPY TECHNOLOGIES MARKET FOR CELL BANKS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 232 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL BANKS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 233 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL BANKS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 234 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CELL BANKS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 235 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL BANKS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 236 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CELL BANKS, BY REGION, 2022-2029 (USD MILLION)
• TABLE 237 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CELL BANKS, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 238 CELL THERAPY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 239 NORTH AMERICA: KEY MACROINDICATORS
• TABLE 240 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 241 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 242 NORTH AMERICA: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 243 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 244 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 245 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 246 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 247 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 248 US: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 249 US: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 250 US: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 251 US: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 252 US: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 253 US: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 254 US: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 255 CANADA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 256 CANADA: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 257 CANADA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 258 CANADA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 259 CANADA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 260 CANADA: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 261 CANADA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 262 EUROPE: KEY MACROINDICATORS
• TABLE 263 EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 264 EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 265 EUROPE: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 266 EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 267 EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 268 EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 269 EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 270 EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 271 GERMANY: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 272 GERMANY: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 273 GERMANY: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 274 GERMANY: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 275 GERMANY: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 276 GERMANY: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 277 GERMANY: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 278 UK: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 279 UK: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 280 UK: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 281 UK: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 282 UK: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 283 UK: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 284 UK: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 285 FRANCE: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 286 FRANCE: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 287 FRANCE: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 288 FRANCE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 289 FRANCE: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 290 FRANCE: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 291 FRANCE: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 292 ITALY: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 293 ITALY: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 294 ITALY: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 295 ITALY: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 296 ITALY: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 297 ITALY: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 298 ITALY: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 299 SPAIN: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 300 SPAIN: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 301 SPAIN: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 302 SPAIN: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 303 SPAIN: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 304 SPAIN: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 305 SPAIN: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 306 REST OF EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 307 REST OF EUROPE: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 308 REST OF EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 309 REST OF EUROPE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 310 REST OF EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 311 REST OF EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 312 REST OF EUROPE: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 313 ASIA PACIFIC: KEY MACROINDICATORS
• TABLE 314 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 315 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 316 ASIA PACIFIC: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 317 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 318 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 319 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 320 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 321 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 322 CHINA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 323 CHINA: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 324 CHINA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 325 CHINA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 326 CHINA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 327 CHINA: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 328 CHINA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 329 JAPAN: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 330 JAPAN: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 331 JAPAN: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 332 JAPAN: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 333 JAPAN: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 334 JAPAN: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 335 JAPAN: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 336 INDIA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 337 INDIA: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 338 INDIA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 339 INDIA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 340 INDIA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 341 INDIA: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 342 INDIA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 343 AUSTRALIA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 344 AUSTRALIA: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 345 AUSTRALIA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 346 AUSTRALIA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 347 AUSTRALIA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 348 AUSTRALIA: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 349 AUSTRALIA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 350 SOUTH KOREA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 351 SOUTH KOREA: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 352 SOUTH KOREA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 353 SOUTH KOREA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 354 SOUTH KOREA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 355 SOUTH KOREA: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 356 SOUTH KOREA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 357 REST OF ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 358 REST OF ASIA PACIFIC: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 359 REST OF ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 360 REST OF ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 361 REST OF ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 362 REST OF ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 363 REST OF ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 364 LATIN AMERICA: KEY MACROINDICATORS
• TABLE 365 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 366 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 367 LATIN AMERICA: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 368 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 369 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 370 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 371 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 372 LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 373 BRAZIL: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 374 BRAZIL: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 375 BRAZIL: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 376 BRAZIL: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 377 BRAZIL: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 378 BRAZIL: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 379 BRAZIL: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 380 MEXICO: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 381 MEXICO: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 382 MEXICO: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 383 MEXICO: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 384 MEXICO: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 385 MEXICO: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 386 MEXICO: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 387 REST OF LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 388 REST OF LATIN AMERICA: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 389 REST OF LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 390 REST OF LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 391 REST OF LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 392 REST OF LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 393 REST OF LATIN AMERICA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 394 MIDDLE EAST: KEY MACROINDICATORS
• TABLE 395 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET, BY REGION, 2022-2029 (USD MILLION)
• TABLE 396 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 397 MIDDLE EAST: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 398 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 399 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 400 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 401 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 402 MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 403 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
• TABLE 404 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 405 GCC COUNTRIES: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 406 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 407 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 408 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 409 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 410 GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 411 SAUDI ARABIA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 412 SAUDI ARABIA: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 413 SAUDI ARABIA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 414 SAUDI ARABIA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 415 SAUDI ARABIA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 416 SAUDI ARABIA: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 417 SAUDI ARABIA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 418 UAE: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 419 UAE: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 420 UAE: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 421 UAE: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 422 UAE: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 423 UAE: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 424 UAE: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 425 REST OF GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 426 REST OF GCC COUNTRIES: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 427 REST OF GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 428 REST OF GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 429 REST OF GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 430 REST OF GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 431 REST OF GCC COUNTRIES: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 432 REST OF MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 433 REST OF MIDDLE EAST: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 434 REST OF MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 435 REST OF MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 436 REST OF MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 437 REST OF MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 438 REST OF MIDDLE EAST: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 439 AFRICA: KEY MACROINDICATORS
• TABLE 440 AFRICA: CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2022-2029 (USD MILLION)
• TABLE 441 AFRICA: CELL THERAPY EQUIPMENT MARKET, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 442 AFRICA: CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2022-2029 (USD MILLION)
• TABLE 443 AFRICA: CELL THERAPY TECHNOLOGIES MARKET FOR CELL PROCESSING, BY TYPE, 2022-2029 (USD MILLION)
• TABLE 444 AFRICA: CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2022-2029 (USD MILLION)
• TABLE 445 AFRICA: CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
• TABLE 446 AFRICA: CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2022-2029 (USD MILLION)
• TABLE 447 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, 2021-2023
• TABLE 448 CELL THERAPY TECHNOLOGIES MARKET: DEGREE OF COMPETITION
• TABLE 449 CELL THERAPY TECHNOLOGIES MARKET: REGION FOOTPRINT
• TABLE 450 CELL THERAPY TECHNOLOGIES MARKET: PRODUCT FOOTPRINT
• TABLE 451 CELL THERAPY TECHNOLOGIES MARKET: PROCESS FOOTPRINT
• TABLE 452 CELL THERAPY TECHNOLOGIES MARKET: CELL TYPE FOOTPRINT
• TABLE 453 CELL THERAPY TECHNOLOGIES MARKET: APPLICATION FOOTPRINT
• TABLE 454 CELL THERAPY TECHNOLOGIES MARKET: DETAILED LIST OF KEY STARTUPS/SMES
• TABLE 455 CELL THERAPY TECHNOLOGIES MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
• TABLE 456 CELL THERAPY TECHNOLOGIES MARKET: PRODUCT LAUNCHES, JANUARY 2021-NOVEMBER 2024
• TABLE 457 CELL THERAPY TECHNOLOGIES MARKET: DEALS, JANUARY 2021- NOVEMBER 2024
• TABLE 458 CELL THERAPY TECHNOLOGIES MARKET: EXPANSIONS, JANUARY 2021- NOVEMBER 2024
• TABLE 459 DANAHER CORPORATION: COMPANY OVERVIEW
• TABLE 460 DANAHER CORPORATION: PRODUCTS OFFERED
• TABLE 461 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021- OCTOBER 2024
• TABLE 462 DANAHER CORPORATION: DEALS, JANUARY 2021- OCTOBER 2024
• TABLE 463 DANAHER CORPORATION: EXPANSIONS, JANUARY 2021- OCTOBER 2024
• TABLE 464 MERCK KGAA: COMPANY OVERVIEW
• TABLE 465 MERCK KGAA: PRODUCTS OFFERED
• TABLE 466 MERCK KGAA: DEALS, JANUARY 2021-SEPTEMBER 2024
• TABLE 467 MERCK KGAA: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
• TABLE 468 THERMO FISHER SCIENTIFIC INC: COMPANY OVERVIEW
• TABLE 469 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED
• TABLE 470 THERMO FISHER SCIENTIFIC INC: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
• TABLE 471 THERMO FISHER SCIENTIFIC INC: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 472 THERMO FISHER SCIENTIFIC INC: EXPANSIONS, JANUARY 2021-OCTOBER 2024
• TABLE 473 LONZA: COMPANY OVERVIEW
• TABLE 474 LONZA: PRODUCTS OFFERED
• TABLE 475 LONZA: PRODUCT LAUNCHES, JANUARY 2021- OCTOBER 2024
• TABLE 476 LONZA: DEALS, JANUARY 2021- OCTOBER 2024
• TABLE 477 SARTORIUS: COMPANY OVERVIEW
• TABLE 478 SARTORIUS AG: PRODUCTS OFFERED
• TABLE 479 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2021-OCTOBER 2024
• TABLE 480 SARTORIUS AG: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 481 SARTORIUS AG: EXPANSIONS, JANUARY 2021- OCTOBER 2024
• TABLE 482 AGILENT TECHNOLOGIES: COMPANY OVERVIEW
• TABLE 483 AGILENT TECHNOLOGIES: PRODUCTS OFFERED
• TABLE 484 AGILENT TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2021-OCTOBER 2024
• TABLE 485 AGILENT TECHNOLOGIES: DEALS, JANUARY 2021- OCTOBER 2024
• TABLE 486 AVANTOR: COMPANY OVERVIEW
• TABLE 487 AVANTOR: PRODUCTS OFFERED
• TABLE 488 AVANTOR: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 489 FRESENIUS: COMPANY OVERVIEW
• TABLE 490 FRESENIUS: PRODUCTS OFFERED
• TABLE 491 FRESENIUS: DEALS, JANUARY 2021-SEPTEMBER 2024
• TABLE 492 BD: COMPANY OVERVIEW
• TABLE 493 BD: PRODUCTS OFFERED
• TABLE 494 BD: PRODUCT LAUNCHES, JANUARY 2021- OCTOBER 2024
• TABLE 495 CORNING INCORPORATED: COMPANY OVERVIEW
• TABLE 496 CORNING INCORPORATED: PRODUCTS OFFERED
• TABLE 497 TERUMO CORPORATION: COMPANY OVERVIEW
• TABLE 498 TERUMO CORPORATION: PRODUCTS OFFERED
• TABLE 499 TERUMO CORPORATION: PRODUCT LAUNCHES, JANUARY 2021-OCTOBER 2024
• TABLE 500 TERUMO CORPORATION: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 501 TERUMO CORPORATION: EXPANSIONS, JANUARY 2021-OCTOBER 2024
• TABLE 502 BIO-TECHNE: COMPANY OVERVIEW
• TABLE 503 BIO-TECHNE: PRODUCTS OFFERED
• TABLE 504 BIO-TECHNE: PRODUCT LAUNCHES, JANUARY 2021-OCTOBER 2024
• TABLE 505 BIO-TECHNE: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 506 BIO-TECHNE: OTHER DEVELOPMENTS, JANUARY 2021-OCTOBER 2024
• TABLE 507 GENSCRIPT: COMPANY OVERVIEW
• TABLE 508 GENSCRIPT: PRODUCTS OFFERED
• TABLE 509 GENSCRIPT: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 510 MAXCYTE: COMPANY OVERVIEW
• TABLE 511 MAXCYTE: PRODUCTS OFFERED
• TABLE 512 MAXCYTE: DEALS, JANUARY 2021-OCTOBER 2024
• TABLE 513 STEMCELL TECHNOLOGIES: COMPANY OVERVIEW
• TABLE 514 STEMCELL TECHNOLOGIES: PRODUCTS OFFERED
• TABLE 515 STEMCELL TECHNOLOGIES: PRODUCT LAUNCHES, JANUARY 2021- OCTOBER 2024
• TABLE 516 STEMCELL TECHNOLOGIES: DEALS, JANUARY 2021-OCTOBER 2024

List of Figures

• FIGURE 1 CELL THERAPY TECHNOLOGIES MARKET SEGMENTATION AND REGIONAL SCOPE
• FIGURE 2 CELL THERAPY TECHNOLOGIES MARKET: RESEARCH DESIGN
• FIGURE 3 CELL THERAPY TECHNOLOGIES MARKET: BREAKDOWN OF PRIMARY INTERVIEWS
• FIGURE 4 CELL THERAPY TECHNOLOGIES MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
• FIGURE 5 MARKET SIZE ESTIMATION APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
• FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS (2023)
• FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
• FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
• FIGURE 9 CELL THERAPY TECHNOLOGIES MARKET: CAGR PROJECTIONS
• FIGURE 10 DATA TRIANGULATION METHODOLOGY
• FIGURE 11 CELL THERAPY TECHNOLOGIES MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
• FIGURE 12 CELL THERAPY TECHNOLOGIES MARKET, BY PROCESS, 2024 VS. 2029 (USD MILLION)
• FIGURE 13 CELL THERAPY TECHNOLOGIES MARKET, BY CELL TYPE, 2024 VS. 2029 (USD MILLION)
• FIGURE 14 CELL THERAPY TECHNOLOGIES MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
• FIGURE 15 CELL THERAPY TECHNOLOGIES MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
• FIGURE 16 GEOGRAPHICAL SNAPSHOT OF CELL THERAPY TECHNOLOGIES MARKET (2024-2029)
• FIGURE 17 INCREASED FUNDING & INVESTMENT IN CELL THERAPY AND ADVANCEMENTS IN GENE EDITING TECHNOLOGIES TO DRIVE MARKET
• FIGURE 18 US ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
• FIGURE 19 MEDIA, SERA, AND REAGENTS TO DOMINATE MARKET DURING FORECAST PERIOD
• FIGURE 20 APAC COUNTRIES TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
• FIGURE 21 CELL THERAPY TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
• FIGURE 22 CELL THERAPY TECHNOLOGIES MARKET: ECOSYSTEM
• FIGURE 23 AVERAGE SELLING PRICE TREND OF CELL THERAPY EQUIPMENT, 2024 (USD THOUSAND)
• FIGURE 24 CELL THERAPY TECHNOLOGIES MARKET: VALUE CHAIN ANALYSIS
• FIGURE 25 CELL THERAPY TECHNOLOGIES MARKET: OVERVIEW OF PATENTING ACTIVITY
• FIGURE 26 CELL THERAPY TECHNOLOGIES MARKET: PORTER'S FIVE FORCES ANALYSIS
• FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
• FIGURE 28 KEY BUYING CRITERIA FOR TOP FOUR END USERS
• FIGURE 29 GOVERNMENT FUNDING FOR R&D FROM 2019-2024
• FIGURE 30 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• FIGURE 31 CELL THERAPY TECHNOLOGIES MARKET: IMPACT OF AI
• FIGURE 32 NORTH AMERICA: CELL THERAPY TECHNOLOGIES MARKET SNAPSHOT
• FIGURE 33 ASIA PACIFIC: CELL THERAPY TECHNOLOGIES MARKET SNAPSHOT
• FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN CELL THERAPY TECHNOLOGIES MARKET, 2021-2023
• FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL THERAPY TECHNOLOGIES MARKET, 2023
• FIGURE 36 CELL THERAPY TECHNOLOGIES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
• FIGURE 37 CELL THERAPY TECHNOLOGIES MARKET: COMPANY FOOTPRINT
• FIGURE 38 CELL THERAPY TECHNOLOGIES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
• FIGURE 39 EV/EBITDA OF KEY VENDORS
• FIGURE 40 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
• FIGURE 41 CELL THERAPY TECHNOLOGIES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
• FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT
• FIGURE 43 MERCK KGAA: COMPANY SNAPSHOT
• FIGURE 44 THERMO FISHER SCIENTIFIC INC: COMPANY SNAPSHOT
• FIGURE 45 LONZA: COMPANY SNAPSHOT
• FIGURE 46 SARTORIUS AG: COMPANY SNAPSHOT
• FIGURE 47 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
• FIGURE 48 AVANTOR: COMPANY SNAPSHOT
• FIGURE 49 FRESENIUS: COMPANY SNAPSHOT
• FIGURE 50 BD: COMPANY SNAPSHOT
• FIGURE 51 CORNING INCORPORATED: COMPANY SNAPSHOT
• FIGURE 52 TERUMO CORPORATION: COMPANY SNAPSHOT
• FIGURE 53 BIO-TECHNE: COMPANY SNAPSHOT
• FIGURE 54 GENSCRIPT: COMPANY SNAPSHOT
• FIGURE 55 MAXCYTE: COMPANY SNAPSHOT